Literature DB >> 20701853

Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel-based sex workers in India.

Kamalesh Sarkar1, Swati Bhattacharya, Subhasish Bhattacharyya, Soma Chatterjee, Aiyel Haque Mallick, Sekhar Chakraborti, Debashree Chatterjee, Baishali Bal.   

Abstract

A community-based cross-sectional study was conducted in brothel-based sex workers of West Bengal, Eastern India, to determine their oncogenic human papillomavirus (HPV) status and the presence of pre-cancerous lesions. A total of 229 sex workers from three districts of West Bengal participated in the study. All the study participants were interviewed with the aid of a pre-tested questionnaire to determine their sociodemographics, risk behaviour and risk perceptions after obtaining informed verbal consent. The interview was followed by collection of cervical cells from all participants using a disposable vaginal speculum and cervical cytobrush. Oncogenic HPV DNA was detected by real-time polymerase chain reaction (PCR). A simultaneous Papanicolaou test ('Pap smear') was performed to detect cervical cytological abnormalities. Overall, the prevalence of oncogenic HPV was found to be 25% (58/229) among the studied population. A subset (n=112) of the sample was tested separately to determine the existence and magnitude of HPV genotypes 16 and 18. The results showed that genotype 16 was prevalent in 10% (11/112), genotype 18 in 7% (8/112) and both genotype 16 and 18 in 7% (8/112). The HPV prevalence rate showed a decreasing trend with age, being 71.4% in the 10-19 years age group, 32.3% in the 20-29 years age group, 18.3% in the 30-39 years age group and 2.5% in the >or=40 years age group (statistically significant differences, P<or=0.00001). Considering the duration of sex work, oncogenic HPV prevalence was found to be 55% (n=21) and 19% (n=35) in sex workers with a sex working duration of <or=1 year and >1 year, respectively. This difference was found to be statistically significant both by univariate and multivariate analysis. In this study, it was observed that sex workers with an average number of daily clients of six or more had an HPV prevalence of 67% (n=6), those with four to five clients had a prevalence of 45% (n=9), those with two to three clients had a prevalence of 30% (n=34) and those with one or less clients had a prevalence of 10% (n=9) (statistically significant differences, P=0.00003). Multivariate analysis showed a statistical association only with a duration of sex work of <or=1 year [odds ratio (OR)=3.3; 95% confidence interval (CI) 1.4-7.6] and daily income of Rupees (Rp) >or=101 (OR=2.5; 95% CI 1.3-5). Regarding pre-cancerous lesions, 2 of 229 sex workers showed the presence of a low-grade squamous intraepithelial lesion along with high-risk HPV. Thus, 1% of the studied population suffer from a pre-cancerous lesion caused by high-risk HPV. This study concludes that young sex workers are particularly vulnerable to high-risk HPV, similar to human immunodeficiency virus (HIV). The observation of older sex workers relatively free from HPV supports the view of acquired immunity against HPV, which needs to be studied in-depth further. There is a need for a suitable community-based intervention programme targeted towards sex workers, with special reference to younger sex workers, for control and prevention of HPV and cervical cancer. Vaccination against HPV for newly entrant sex workers may be an important component for a successful intervention programme. Copyright (c) 2008 King Saud Bin Abdulaziz University for Health Sciences. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20701853     DOI: 10.1016/j.jiph.2008.09.001

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  8 in total

1.  Oncogenic HPV among HIV infected female population in West Bengal, India.

Authors:  Kamalesh Sarkar; Reshmi Pal; Baishali Bal; Bibhuti Saha; Subhasish Bhattacharya; Sharmila Sengupta; Partha Pratim Mazumdar; Shekhar Chakraborti
Journal:  BMC Infect Dis       Date:  2011-03-22       Impact factor: 3.090

2.  Molecular genotyping of human papillomavirus l1 gene in low-risk and high-risk populations in Bangkok.

Authors:  Pornsawan Leaungwutiwong; Busara Bamrungsak; Akanitt Jittmittraphap; Pannamas Maneekan; Nathamon Kosoltanapiwat; Thareerat Kalambaheti; James F Kelley
Journal:  Sex Transm Dis       Date:  2015-04       Impact factor: 2.830

Review 3.  Epidemiology of cervical cancer with special focus on India.

Authors:  Aswathy Sreedevi; Reshma Javed; Avani Dinesh
Journal:  Int J Womens Health       Date:  2015-04-16

4.  Human papillomavirus genotype distribution and factors associated among female sex workers in West Africa.

Authors:  Fatoumata Korika Tounkara; Ibrahima Téguété; Fernand A Guédou; Ella Goma-Matsétsé; Amadou Koné; Luc Béhanzin; Sidy Traoré; Marlène Aza-Gnandji; Bintou Keita; Julie Guenoun; François Coutlée; Michel Alary
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

5.  Oncogenic human papillomavirus DNA in female sex workers of Bihar, India.

Authors:  Akhtar Parwez; Sunit Singh; Rahul Kumar; Sristy Kumari; Arun Kumar; Mohammad Ali
Journal:  Int J Health Sci (Qassim)       Date:  2022 Mar-Apr

Review 6.  Analysis of duration of risk behaviour for key populations: a literature review.

Authors:  Erika Fazito; Paloma Cuchi; Mary Mahy; Tim Brown
Journal:  Sex Transm Infect       Date:  2012-12       Impact factor: 3.519

7.  PCR and Genotyping for HPV in Cervical Cancer Patients.

Authors:  Pradyot Prakash; Shashikant C U Patne; Ashish Kumar Singh; Mohan Kumar; Mukti Nath Mishra; Anil Kumar Gulati
Journal:  J Glob Infect Dis       Date:  2016 Jul-Sep

8.  Prevalence and genotype distribution of genital human papillomavirus infection in female sex workers in the world: a systematic review and meta-analysis.

Authors:  Mohammad Farahmand; Mohsen Moghoofei; Abolfazl Dorost; Saeedeh Abbasi; Seyed Hamidreza Monavari; Seyed Jalal Kiani; Ahmad Tavakoli
Journal:  BMC Public Health       Date:  2020-09-25       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.